Nanoparticles as new tools for inhibition of cancer angiogenesis

Abstract

Angiogenesis is known as one of the hallmarks of cancer. Multiple lines evidence indicated that vascular endothelium growth factor (VEGF) is a key player in the progression of angiogenesis and exerts its functions via interaction with tyrosine kinase receptors (TKRs). These receptors could trigger a variety of cascades that lead to the supply of oxygen and nutrients to tumor cells and survival of these cells. With respect to pivotal role of angiogenesis in the tumor growth and survival, finding new therapeutic approaches via targeting angiogenesis could open a new horizon in cancer therapy. Among various types of therapeutic strategies, nanotechnology has emerged as new approach for the treatment of various cancers. Nanoparticles (NPs) could be used as effective tools for targeting a variety of therapeutic agents. According to in vitro and in vivo studies, NPs are efficient in depriving tumor cells from nutrients and oxygen by inhibiting angiogenesis. However, the utilization of NPs are associated with a variety of limitations. It seems that new approaches such as NPs conjugated with hydrogels could overcome to some limitations. In the present review, we summarize various mechanisms involved in angiogenesis, common anti-angiogenesis strategies, and application of NPs for targeting angiogenesis in various cancers.

Fusobacterium nucleatum and colorectal cancer: A mechanistic overview

“…There are many conditions that promote angiogenesis, such as hypoxia. Under hypoxia condition, hypoxia‐inducible factor‐1 (HIF‐1) increases the expression of angiogenesis growth factors, including vascular endothelial growth factor (VEGF) and its receptors (VEGFRs; Hashemi Goradel et al, ). Consistent with this proposal, Mendes et al () reported that infection of epithelial cells with F. nucleatum increases angiogenesis via upregulating VEGF and VEGFR1 and 2.…”

MicroRNA: A novel target of curcumin in cancer therapy

“…MiRNAs are known as small non‐coding RNAs which have central roles in vital physiological events such as apoptosis, angiogenesis, growth, and differentiation (Gholamin et al, ; Goradel et al, ; Hashemi Goradel et al, ; Reza Mirzaei et al, ; Salarinia et al, ). Hence, deregulation of these molecules could lead to activation/inhibition various molecular and cellular targets which could contribute to initiation and progression of cancer.…”

MicroRNAs and response to therapy in leukemia

“…miRNAs are a group of noncoding RNAs, which act epigenetic players. Given that these molecules can affect a wide range of biological processes, such as growth, angiogenesis, differentiation, metastasis, and differentiation of stem cells . Given that deregulation of miRNAs are related with initiation and progression of a large number of diseases, such as cancer, diabetes, stroke, cardiovascular diseases, viral infections, and degenerative diseases .…”